News
President Donald Trump sent letters to 17 pharmaceutical CEOs demanding lower drug prices within 60 days, following an executive order signed earlier this year. According to the letter, the order is ...
Trump gave the companies 60 days to voluntarily comply, threatening to "deploy every tool in our arsenal to protect American ...
President Trump escalated efforts to reduce drug prices in the US on Thursday, releasing letters sent to 17 pharmaceutical ...
In 17 identical letters posted to his Truth Social account, the president said companies must lower their prices or the ...
Lawmakers warn the arrangement Eli Lilly and Pfizer have with telehealth platforms may lead to conflicts of interest, subpar ...
In letters posted on Truth Social, Trump demanded that drugmakers offer their medications at the same prices paid abroad.
Weight loss drug giant Eli Lilly and Company (NYSE:LLY)’s shares have struggled in 2025 as they have lost 2.3% year-to-date.
White House Press Secretary Karoline Leavitt announced at Thursday's press conference that President Donald Trump had signed ...
Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo ...
President Donald Trump sent a letter to 17 drug companies demanding a commitment to bring down prices in the next 60 days through a series of initiatives.
Shares of Eli Lilly & Co. erased gains to trade down nearly 1% after White House press secretary Karoline Leavitt said the company was among 17 drugmakers that will be receiving letters from President ...
Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results